US Stocks

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. is a US-based pharmaceutical company that develops and commercializes products for treating CNS diseases, metabolic critical care, and oncology. The company offers products such as Ryanodex for malignant hyperthermia, Belrapzo and Bendeka for chronic lymphocytic leukemia, and indolent B-cell non-Hodgkin's lymphoma, among others. Eagle Pharmaceuticals, Inc. has license and collaboration agreements with Combioxin and AOP Orphan Pharmaceuticals GmbH for the development and commercialization of different therapeutic products for pneumonia and patients with supraventricular tachycardia, respectively.